Vir Biotechnology IncNASDAQ:VIR
- LAST PRICE7.4900
- TODAY'S CHANGE (%)-0.0400 (-0.5312%)
- Bid / Lots7.2500/ 1
- Ask / Lots7.4800/ 2
- Open / Previous Close7.4500 / 7.5300
- Day Range
- 52 Week Range
- Volume553,751
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VIR |
|---|---|---|
| 09:32 ET | 6701 | 7.45 |
| 09:34 ET | 1970 | 7.5099 |
| 09:36 ET | 200 | 7.55 |
| 09:38 ET | 2043 | 7.55 |
| 09:39 ET | 2550 | 7.56 |
| 09:41 ET | 700 | 7.585 |
| 09:43 ET | 100 | 7.58 |
| 09:45 ET | 1700 | 7.63 |
| 09:48 ET | 4228 | 7.64 |
| 09:50 ET | 1784 | 7.68 |
| 09:52 ET | 500 | 7.67 |
| 09:54 ET | 349 | 7.67 |
| 09:56 ET | 400 | 7.67 |
| 09:57 ET | 1542 | 7.67 |
| 09:59 ET | 171 | 7.67 |
| 10:01 ET | 145 | 7.67 |
| 10:03 ET | 5131 | 7.7 |
| 10:06 ET | 2000 | 7.7 |
| 10:08 ET | 36316 | 7.7385 |
| 10:10 ET | 200 | 7.739 |
| 10:12 ET | 2300 | 7.75 |
| 10:14 ET | 4340 | 7.7502 |
| 10:15 ET | 2500 | 7.735 |
| 10:17 ET | 6988 | 7.74 |
| 10:19 ET | 800 | 7.75 |
| 10:21 ET | 600 | 7.75 |
| 10:24 ET | 100 | 7.75 |
| 10:26 ET | 3425 | 7.75 |
| 10:28 ET | 800 | 7.72 |
| 10:30 ET | 700 | 7.71 |
| 10:32 ET | 148 | 7.715 |
| 10:33 ET | 574 | 7.705 |
| 10:35 ET | 4313 | 7.73 |
| 10:37 ET | 565 | 7.72 |
| 10:39 ET | 200 | 7.72 |
| 10:42 ET | 100 | 7.71 |
| 10:44 ET | 100 | 7.7 |
| 10:46 ET | 955 | 7.685 |
| 10:48 ET | 200 | 7.675 |
| 10:50 ET | 400 | 7.68 |
| 10:51 ET | 400 | 7.65 |
| 10:53 ET | 606 | 7.66 |
| 10:55 ET | 306 | 7.66 |
| 10:57 ET | 100 | 7.655 |
| 11:00 ET | 229 | 7.665 |
| 11:04 ET | 200 | 7.665 |
| 11:06 ET | 842 | 7.67 |
| 11:08 ET | 100 | 7.68 |
| 11:09 ET | 521 | 7.66 |
| 11:11 ET | 500 | 7.65 |
| 11:13 ET | 259 | 7.645 |
| 11:15 ET | 310 | 7.66 |
| 11:18 ET | 100 | 7.66 |
| 11:20 ET | 1127 | 7.64 |
| 11:22 ET | 9739 | 7.63 |
| 11:24 ET | 7615 | 7.62 |
| 11:26 ET | 836 | 7.63 |
| 11:27 ET | 400 | 7.63 |
| 11:29 ET | 100 | 7.61 |
| 11:31 ET | 300 | 7.59 |
| 11:33 ET | 800 | 7.58 |
| 11:36 ET | 984 | 7.57 |
| 11:38 ET | 2200 | 7.56 |
| 11:40 ET | 300 | 7.56 |
| 11:42 ET | 200 | 7.5425 |
| 11:44 ET | 430 | 7.52 |
| 11:45 ET | 100 | 7.53 |
| 11:47 ET | 437 | 7.53 |
| 11:49 ET | 100 | 7.515 |
| 11:51 ET | 200 | 7.51 |
| 11:54 ET | 4146 | 7.47 |
| 11:56 ET | 2623 | 7.465 |
| 11:58 ET | 2853 | 7.475 |
| 12:00 ET | 300 | 7.4799 |
| 12:03 ET | 846 | 7.47 |
| 12:05 ET | 400 | 7.465 |
| 12:07 ET | 2474 | 7.459 |
| 12:09 ET | 1948 | 7.47 |
| 12:12 ET | 900 | 7.46 |
| 12:14 ET | 1208 | 7.46 |
| 12:16 ET | 1200 | 7.46 |
| 12:18 ET | 757 | 7.47 |
| 12:20 ET | 1819 | 7.47 |
| 12:21 ET | 302 | 7.47 |
| 12:23 ET | 1365 | 7.47 |
| 12:25 ET | 1100 | 7.48 |
| 12:27 ET | 1000 | 7.4797 |
| 12:30 ET | 1369 | 7.49 |
| 12:32 ET | 321 | 7.5 |
| 12:34 ET | 291 | 7.5 |
| 12:36 ET | 100 | 7.5 |
| 12:38 ET | 1904 | 7.4993 |
| 12:39 ET | 600 | 7.496 |
| 12:41 ET | 400 | 7.49 |
| 12:43 ET | 460 | 7.49 |
| 12:45 ET | 300 | 7.495 |
| 12:48 ET | 200 | 7.5 |
| 12:50 ET | 114 | 7.495 |
| 12:52 ET | 100 | 7.495 |
| 12:54 ET | 746 | 7.49 |
| 12:57 ET | 760 | 7.48 |
| 12:59 ET | 365 | 7.48 |
| 01:01 ET | 725 | 7.48 |
| 01:03 ET | 1300 | 7.46 |
| 01:06 ET | 460 | 7.4783 |
| 01:08 ET | 1200 | 7.4693 |
| 01:10 ET | 2993 | 7.49 |
| 01:12 ET | 275 | 7.49 |
| 01:14 ET | 1241 | 7.48 |
| 01:17 ET | 2379 | 7.4701 |
| 01:19 ET | 200 | 7.475 |
| 01:21 ET | 570 | 7.475 |
| 01:28 ET | 100 | 7.475 |
| 01:30 ET | 700 | 7.47 |
| 01:33 ET | 400 | 7.465 |
| 01:35 ET | 1241 | 7.46 |
| 01:37 ET | 300 | 7.4597 |
| 01:39 ET | 4665 | 7.48 |
| 01:42 ET | 1975 | 7.47 |
| 01:44 ET | 300 | 7.48 |
| 01:46 ET | 1051 | 7.475 |
| 01:48 ET | 200 | 7.47 |
| 01:53 ET | 100 | 7.475 |
| 01:55 ET | 200 | 7.47 |
| 01:57 ET | 2405 | 7.49 |
| 02:00 ET | 170 | 7.49 |
| 02:04 ET | 1211 | 7.49 |
| 02:06 ET | 300 | 7.495 |
| 02:08 ET | 100 | 7.49 |
| 02:09 ET | 1313 | 7.4895 |
| 02:11 ET | 343 | 7.4848 |
| 02:13 ET | 600 | 7.47 |
| 02:15 ET | 3300 | 7.455 |
| 02:18 ET | 759 | 7.465 |
| 02:20 ET | 729 | 7.455 |
| 02:22 ET | 1000 | 7.44 |
| 02:24 ET | 1666 | 7.435 |
| 02:26 ET | 1912 | 7.41 |
| 02:27 ET | 1042 | 7.425 |
| 02:29 ET | 252 | 7.43 |
| 02:31 ET | 615 | 7.425 |
| 02:33 ET | 200 | 7.43 |
| 02:36 ET | 1761 | 7.435 |
| 02:38 ET | 900 | 7.44 |
| 02:40 ET | 1138 | 7.46 |
| 02:42 ET | 349 | 7.47 |
| 02:45 ET | 685 | 7.47 |
| 02:47 ET | 352 | 7.485 |
| 02:49 ET | 702 | 7.5 |
| 02:51 ET | 100 | 7.5 |
| 02:54 ET | 1120 | 7.46 |
| 02:56 ET | 676 | 7.47 |
| 02:58 ET | 944 | 7.455 |
| 03:00 ET | 2808 | 7.45 |
| 03:02 ET | 2390 | 7.43 |
| 03:03 ET | 100 | 7.44 |
| 03:05 ET | 1733 | 7.445 |
| 03:07 ET | 206 | 7.46 |
| 03:09 ET | 406 | 7.445 |
| 03:12 ET | 654 | 7.45 |
| 03:14 ET | 1303 | 7.435 |
| 03:16 ET | 470 | 7.44 |
| 03:18 ET | 925 | 7.435 |
| 03:20 ET | 2062 | 7.45 |
| 03:21 ET | 100 | 7.45 |
| 03:25 ET | 666 | 7.46 |
| 03:30 ET | 561 | 7.45 |
| 03:32 ET | 1011 | 7.45 |
| 03:34 ET | 1244 | 7.445 |
| 03:36 ET | 601 | 7.435 |
| 03:38 ET | 100 | 7.435 |
| 03:39 ET | 2623 | 7.44 |
| 03:41 ET | 1500 | 7.435 |
| 03:43 ET | 1136 | 7.45 |
| 03:45 ET | 200 | 7.445 |
| 03:48 ET | 2611 | 7.46 |
| 03:50 ET | 3027 | 7.465 |
| 03:52 ET | 2572 | 7.48 |
| 03:54 ET | 1010 | 7.485 |
| 03:56 ET | 5966 | 7.48 |
| 03:57 ET | 5822 | 7.51 |
| 03:59 ET | 174731 | 7.49 |
Sep 10, 2024
Vir Biotechnology Appoints Jason O'Byrne as Chief Financial Officer, from 8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones*DJ Vir Biotechnology Appoints Jason O'Byrne As Chief Financial Officer >VIR, from 8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
Sep 9, 2024
Sep 4, 2024
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031, from 8:30AM ET on Wednesday Sep 04, 2024 by Dow Jones
8:30AM ET on Wednesday Sep 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vir Biotechnology Inc | 1.1B | -2.1x | --- |
Prothena Corporation PLC | 1.2B | -16.6x | --- |
Zymeworks Inc | 890.9M | -8.3x | --- |
Arcutis Biotherapeutics Inc | 1.2B | -4.3x | --- |
Silence Therapeutics PLC | 869.3M | -14.1x | --- |
Silence Therapeutics PLC | 869.3M | -13.3x | --- |
Company Information
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Contact Information
- Headquarters
- 1800 OWENS STREET, SUITE 900SAN FRANCISCO, CA, United States 94158
- Phone
- 415-906-4324
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Vicki Sato
- Chief Executive Officer, Director
- Marianne De Backer
- Executive Vice President, Chief Technology Officer
- Ann Hanly
- Executive Vice President, Chief Scientific Officer
- Jennifer Towne
- Executive Vice President and Chief Business Officer
- Jeffrey Calcagno
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1B |
|---|---|
Revenue (TTM) | $78.9M |
Shares Outstanding | 136.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.46 |
EPS | $-3.58 |
Book Value | $11.80 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | 14.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -715.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
